Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa.

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...